Masimo - Smarter by Design: How Sustainability Drives Better Care and ROI

News

Smarter by Design: How Sustainability Drives Better Care and ROI

Redesigned sensors and packaging that reduce waste, cut costs, and improve performance

April 22, 2025

|

AUTHOR:

Sydnie Aldrich

April 22, 2025

|

AUTHOR:

Sydnie Aldrich

Masimo’s 2024 Sustainability Report highlights how our environmental initiatives aren’t just good for the planet—they’re good for performance. By redesigning our RD SET® sensors and packaging, we’ve cut material waste by 84%, reduced shipping volume by 45%, and saved over 2,900 metric tons of material—all while improving clinical performance. These changes help hospitals meet sustainability goals, reduce storage and disposal costs, and get more value from every device.¹

‍

👉 Download the full Sustainability Report (PDF) for complete information on how Masimo’s innovations deliver both impact and efficiency.¹

‍

¹ Masimo internal data on file.

@Masimo

||

#masimo

Sydnie Aldrich

Phone:

(949) 297-7068

Email:

[email protected]

About Masimo

keyboard_arrow_down

Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Our mission is to improve life, improve patient outcomes, reduce the cost of care, and take noninvasive monitoring to new sites and applications. Masimo SET^® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown to outperform other pulse oximetry technologies in over 100 independent and objective studies, which can be found at www.masimo.com/evidence/featured-studies/feature. Masimo SET^® is estimated to be used on more than 200 million patients around the world each year and is the primary pulse oximetry at all 10 top U.S. hospitals as ranked in the 2025 Newsweek World’s Best Hospitals listing. Additional information about Masimo and its products may be found at www.masimo.com.

‍

keyboard_arrow_down

PLCO-007792/PLM-15260A-0625

@Masimo

||

#masimo

MEDIA CONTACT

Evan Lamb

Phone:

(949) 396-3376

Email:

[email protected]

About Masimo

keyboard_arrow_down

Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Our mission is to improve life, improve patient outcomes, reduce the cost of care, and take noninvasive monitoring to new sites and applications. Masimo SET^® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown to outperform other pulse oximetry technologies in over 100 independent and objective studies, which can be found at www.masimo.com/evidence/featured-studies/feature. Masimo SET^® is estimated to be used on more than 200 million patients around the world each year and is the primary pulse oximetry at all 10 top U.S. hospitals as ranked in the 2025 Newsweek World’s Best Hospitals listing. Additional information about Masimo and its products may be found at www.masimo.com.

‍

PLCO-007792/PLM-15260A-0625

Masimo Announces FDA Clearance of the Rad-G® with Temperature

Masimo (NASDAQ: MASI) today announced that the Rad-G® with Temperature has received FDA 510(k) clearance. Rad-G with Temperature is a rugged, versatile, handheld monitor that provides clinically proven SET® pulse oximetry, respiration rate from the

Next Article ➞